Caplehorn J R, Bell J, Kleinbaum D G, Gebski V J
Department of Public Health, University of Sydney, Australia.
Addiction. 1993 Jan;88(1):119-24. doi: 10.1111/j.1360-0443.1993.tb02769.x.
A retrospective study examined the association between methadone dose and in-treatment heroin use as measured by fixed-interval urine testing in a cohort of 62 patients admitted to an Australian maintenance program. Urinalysis and methadone dose data were collected on subjects for a maximum two years and were analysed using Zeger & Liang's (1986) method for modelling longitudinal data. While allowing for patient descriptors and the time period in which urine samples were collected, the relative odds of using heroin were reduced by 2% for every 1 mg increase in the maintenance dose of methadone. It is estimated that the odds of patients maintained on 40 mg of methadone using heroin were 2.2 times those of patients maintained on 80 mg.
一项回顾性研究调查了在澳大利亚一个维持治疗项目收治的62名患者队列中,通过固定间隔尿液检测衡量的美沙酮剂量与治疗期间海洛因使用之间的关联。收集了受试者最长两年的尿液分析和美沙酮剂量数据,并使用泽格和梁(1986年)的纵向数据建模方法进行分析。在考虑患者特征以及收集尿液样本的时间段的情况下,美沙酮维持剂量每增加1毫克,使用海洛因的相对几率就降低2%。据估计,服用40毫克美沙酮的患者使用海洛因的几率是服用80毫克美沙酮患者的2.2倍。